test TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development...
Wave formation, should push into next Fib. Level. Price target $9.30
Needs good news to actually move, but the chart setup is nice
keeping it simple! We have seemed to reach the bottom 2$ mark once again, and have indicators of a bounce to the top of the wedge, and possible breakout! I see the moku cloud turning bullish slightly, and buy signals in this area firing. We had a weekly sqeeze fire short, which seems to be slowing down right about now, with noticable increased volume over the...